Oral Communications and Posters
Vol. 5 No. s3 (2026): Abstracts of the XXIX National Congress of the Italian Society for the Study of Hemostasis and Thrombosis, 2026

PO010 | D-DIMER TESTING BEYOND THROMBOSIS: A LABORATORY AUDIT OF TEST UTILIZATION, APPROPRIATENESS AND INTERPRETIVE CHALLENGES

A. Mameli1, E. Casula2, E. Poma2, F. Marongiu1, D. Barcellona1 | 1Haemostasis and Thrombosis Unit; 2Laboratory Clinical Chemical Analysis and Microbiology, Azienda Ospedaliero-Universitaria (A.O.U.), Cagliari, Italy

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 26 October 2026
69
Views
27
Downloads

Authors

Background. D-dimer is a high-sensitivity biomarker central to diagnostic algorithms for venous thromboembolism (VTE). However, its low specificity—particularly in elderly and hospitalized patients—limits clinical utility when not integrated with pre-test probability assessment. Inappropriate test utilization may generate diagnostic ambiguity and unnecessary downstream imaging.
Objectives. To evaluate real-world patterns of D-dimer utilization and identify predictors of guideline-adherent testing, focusing on implications for diagnostic stewardship.
Methods. We conducted a retrospective observational study including all consecutive D-dimer requests over a 12-month period at a tertiary care hospital. Appropriateness was defined according to established indications (suspected VTE, acute aortic syndrome, disseminated intravascular coagulation). Demographic, laboratory, and clinical discharge data were collected. Multivariable logistic regression was performed to identify independent predictors of appropriate test use.
Results. A total of 519 D-dimer requests were analyzed. Only a minority met predefined appropriateness criteria, indicating substantial overuse in routine practice. D-dimer levels were elevated in the majority of cases, while values below the conventional 0.5 mg/L FEU cut-off were uncommon. At multivariable analysis, increasing age was independently associated with a lower likelihood of appropriate test utilization (OR 0.98 per year; 95% CI 0.97–0.996; p=0.011), whereas sex was not significantly associated with appropriateness.
Conclusions. In real-world hospital settings, D-dimer testing is frequently performed outside structured diagnostic pathways. Given its high sensitivity but limited specificity—particularly in elderly populations—its indiscriminate use may reduce diagnostic efficiency. Strengthening laboratory–clinician integration and implementing diagnostic stewardship strategies, including age-adjusted thresholds and contextualized reporting, may improve appropriateness and reduce unnecessary downstream investigations.

Downloads

Download data is not yet available.

Citations

How to Cite



1.
Mameli A. PO010 | D-DIMER TESTING BEYOND THROMBOSIS: A LABORATORY AUDIT OF TEST UTILIZATION, APPROPRIATENESS AND INTERPRETIVE CHALLENGES: A. Mameli1, E. Casula2, E. Poma2, F. Marongiu1, D. Barcellona1 | 1Haemostasis and Thrombosis Unit; 2Laboratory Clinical Chemical Analysis and Microbiology, Azienda Ospedaliero-Universitaria (A.O.U.), Cagliari, Italy. Bleeding Thromb Vasc Biol [Internet]. 2026 Oct. 26 [cited 2026 Nov. 20];5(s3). Available from: https://www.btvb.org/btvb/article/view/826